| Structure | Chemical Name | CAS | MF |
|
1-(1-Hydroxy-2-pyridin-3-yl-1H-benzimidazol-6-yl)-ethanone
|
1228551-84-5
|
C14H11N3O2
|
|
1-(2-Hydroxyphenyl)piperazin-4-methylsulfonamide
|
1221792-82-0
|
C11H16N2O3S
|
|
7-Hydroxy-3-isopropyl-4,8-dimethyl-2H-chromen-2-one
|
28814-56-4
|
C14H16O3
|
|
7-Hydroxy-2,5-dimethylpyrazolo[1,5-a]pyrimidine-3-carboxylic acid
|
1158262-66-8
|
C9H9N3O3
|
|
1-(2-Hydroxyphenyl)-4-ethylcarbamoyl-piperazine
|
923121-48-6
|
C13H19N3O2
|
|
3'-Hydroxy-1',3'-dihydro-1H,2'H-3,3'-biindol-2'-one
|
33333-60-7
|
C16H12N2O2
|
|
1-(Hydroxymethyl)cyclobutanecarbonitrile
|
1374657-44-9
|
C5H7NO2
|
|
4-Hydroxy-1,2,5-trimethyl-4-piperidinecarbonitrile
|
51871-79-5
|
C9H16N2O
|
|
4-(Hydroxymethyl)-2-methylaniline
|
|
C8H11NO
|
|
1-Hydroxy-7,8,9,10-tetrahydro-6H-dibenzo[c,h]chromen-6-one
|
5408-46-8
|
C17H14O3
|
|
1-(Hydroxymethyl)cyclopentanecarbonitrile
|
911060-82-7
|
C7H11NO
|
|
3-(4-Hydroxy-phenyl)-propionamidine hydrochloride
|
159239-64-2
|
C9H13ClN2O
|
|
4-Hydroxy-3-[(E)-(phenylimino)methyl]-2H-chromen-2-one
|
360762-44-3
|
C16H11NO3
|
|
[(5-Hydroxy-2,2-dimethyl-4-oxo-3,4-dihydro-2H-chromen-7-yl)oxy]acetic acid
|
135111-51-2
|
C13H14O6
|
|
7-Hydroxy-3-propionyl-2H-chromen-2-one
|
500364-48-7
|
C12H10O4
|
|
7-Hydroxyspiro[chromene-2,1'-cyclohexan]-4(3H)-one
|
62756-43-8
|
C14H16O3
|
|
4-(Hydroxymethyl)tetrahydro-2H-pyran-4-carbonitrile
|
1010836-56-2
|
C7H11NO2
|
|
5-Hydroxy-4,7-dimethyl-2H-chromen-2-one
|
6335-27-9
|
C11H10O3
|
|
1-(2-Hydroxy-ethyl)-6-methyl-1H-benzoimidazole-2-carboxylic acid sodium salt
|
1228070-85-6
|
C11H11N2NaO3
|
|
5-Hydroxy-1-phenyl-1H-pyrazole-4-carboxylic acid
|
|
C10H8N2O3
|
|
2-Hydroxy-4-methylpyridine-3,5-dicarboxylic acid
|
341029-19-4
|
C8H7NO5
|
|
5-Hydroxy-7-methyl-4-phenyl-2H-chromen-2-one
|
52604-30-5
|
C16H12O3
|
|
2-Hydroxyquinoline-4-carbohydrazide
|
41874-24-2
|
C10H9N3O2
|
|
1-(7-Hydroxy[1,2,4]triazolo[1,5-a]pyrimidin-6-yl)-ethanone
|
932736-65-7
|
C7H6N4O2
|
|
2-Hydroxyacetohydrazide
|
|
C2H6N2O2
|
|
1-(4-Hydroxypehnyl)-4-ethylcarbamoyl-piperazine
|
908095-21-6
|
C13H19N3O2
|
|
(7-Hydroxy-8-methyl-2-oxo-2H-chromen-4-yl)-acetic acid
|
68747-36-4
|
C12H10O5
|
|
2-Hydroxy-3-methoxy-7,8,9,10-tetrahydro-6H-benzo[c]chromen-6-one
|
145575-31-1
|
C14H14O4
|
|
7-Hydroxypyrazolo[5,1-c]pyrido[4,3-e][1,2,4]-triazin-6(7H)-one
|
1211170-88-5
|
C8H5N5O2
|
|
7-Hydroxy-3-pentanoyl-2H-chromen-2-one
|
919742-28-2
|
C14H14O4
|
|
4-Hydroxy Testosterone-d3
|
|
C19H28O3
|
|
21-Hydroxy-pregna-1,4,16-triene-3,11,20-trione
|
102447-86-9
|
C21H24O4
|
|
4'-Hydroxy Trazodone-d6 Benzyl Ether
|
|
C26H28ClN5O2
|
|
5-Hydroxy-2,24,6tetrachlorobiphenyl
|
|
|
|
4-Hydroxy TriMethopriM-13C3
|
|
C14H18N4O4
|
|
|
3-Hydroxy-2,26,6tetrachlorobiphenyl
|
|
|
|
16β-Hydroxy Metribolone
|
|
C20H26O2
|
|
10β-Hydroxy Naloxone
|
|
C19H21NO5
|
|
4-Hydroxy TriMethopriM-d9
|
|
C14H18N4O4
|
|
3-Hydroxy-5-nitrophenylboronic Acid Pinacol Ester
|
1158236-73-7
|
C12H16BNO5
|
|
2-Hydroxy-4H-1-benzothiopyran-4-one
|
107514-60-3
|
C9H6O2S
|
|
|
5-Hydroxy-2,23,4,456-heptachlorobiphenyl
|
|
|
|
16β-Hydroxy Stanozolol-d3
|
|
C21H31N2O2
|
|
3α-Hydroxydesoxy ArteMether
|
174097-70-2
|
C16H26O5
|
|
7-Hydroxy CouMarin β-D-Glucuronide Methyl Ester
|
1176514-11-6
|
C16H16O9
|
|
7-Hydroxy CouMarin 2,3,4-Tri-O-acetyl-β-D-glucuronide Methyl Ester
|
168286-97-3
|
C22H22O12
|
|
4-HydroxyMethyl-2-benzylphenyl Isobutyrate
|
1309934-15-3
|
C18H20O3
|
|
|
3Hydroxy-2,23,4,45,5heptachlorobiphenyl
|
|
|
|
ω-Hydroxy FTY720 Hydrochloride
|
1346599-82-3
|
C19H34ClNO3
|
|
21-Hydroxy-pregna-1,4,16-triene-3,11,20-trione 21-Acetate
|
82423-35-6
|
C23H26O5
|
|
(±)-11-Hydroxy-δ9-THC-D3
|
362044-74-4
|
C21H27D3O3
|
|
6β-Hydroxyandrosterone (available to WADA laboratories only)
|
152886-16-3
|
C19H30O3
|
|
4-Hydroxy-2-[2-(methoxycarbonyl)-4-nitrophenyl]isoxazolidine
|
|
C11H12N2O6
|
|
(±)-4-Hydroxyamphetamine hydrochloride (HMA)
|
876-26-6
|
C9H14ClNO
|
|
6β-Hydroxy-oral turinabol
|
25486-01-5
|
C20H27ClO3
|
|
3-{[4-(2-Hydroxyethyl)piperazin-1-yl]carbonyl}benzeneboronic acid hydrochloride 97%
|
|
C13H20BClN2O4
|
|
4-Hydroxy-2-(trifluoroacetyl)aniline, 1-(2-Amino-5-hydroxyphenyl)-2,2,2-trifluoroethan-1-one, 4-Amino-3-(trifluoroacetyl)phenol
|
|
C8H6F3NO2
|
|
3-(Hydroxymethyl)-5-methyl-1H-indole-1-carboxylic acid tert-butyl ester
|
|
C15H19NO3
|
|
2-[(2-Hydroxyethyl)carbamoyl]imidazo[1,2-a]pyridine
|
1157107-85-1
|
C10H11N3O2
|
|
4-Hydroxy-3-hydroxymethyl-1H-indole-1-carboxylic acid tert-butyl ester
|
|
C14H17NO4
|
|
3-(2-{[5-(Hydroxymethyl)-1-methyl-1H-imidazol-2-yl]sulphanyl}ethoxy)benzotrifluoride, 5-(Hydroxymethyl)-1-methyl-2-({2-[3-(trifluoromethyl)phenoxy]ethyl}sulphanyl)-1H-imidazole
|
|
C14H15F3N2O2S
|
|
1-[3-(1-Hydroxy-2,2,2-trifluoroethyl)piperidin-1-yl]-2,2,2-trifluoroethan-1-one
|
|
C9H11F6NO2
|
|
|
3α-Hydroxy-4-estren-17-one (available to WADA laboratories only)
|
|
|
|
3-Hydroxy-2-(trifluoroacetyl)aniline, 1-(2-Amino-6-hydroxyphenyl)-2,2,2-trifluoroethan-1-one, 3-Amino-2-(trifluoroacetyl)phenol
|
|
C8H6F3NO2
|
|
1-Hydroxy-5-iodonaphthalene
|
|
C10H7IO
|
|
|
(±)-4-Hydroxy-3-methoxymandelic Acid-D3 (ring-D3) (VMA-D3)
|
|
|
|
6-(Hydroxymethyl)isoquinoline
|
|
C10H9NO
|
|
3-(hydroxyMethyl)cyclobutanecarboxylic acid
|
1015856-00-4
|
C6H10O3
|
|
1-[4-(1-Hydroxy-2,2,2-trifluoroethyl)piperidin-1-yl]-2,2,2-trifluoroethan-1-one
|
|
C9H11F6NO2
|
|
|
4-Hydroxy-3-methoxyphenyl-D3-acetic-D2 Acid (HVA-D5)
|
|
|
|
6β-Hydroxyetiocholanolone (available to WADA laboratories only)
|
14357-02-9
|
C19H30O3
|
|
4-Hydroxy-4-(trifluoromethyl)hepta-1,6-diene
|
36610-32-9
|
C8H11F3O
|
|
2-Hydroxymethyl-17α-methylandrostadiene-11α,17β-diol-3-one
|
59400-02-1
|
C21H30O4
|
|
4β-Hydroxy DHEA (available to WADA laboratories only)
|
63518-24-1
|
C19H28O3
|
|
4-Hydroxyisophthalic acid 3-methyl ester
|
41684-11-1
|
C9H8O5
|
|
17α-Hydroxyprogesterone-D8 (2,2,4,6,6,21,21,21-D8)
|
850023-80-2
|
C21H30O3
|
|
3-(Hydroxymethyl)-6-methoxy-1H-indole-1-carboxylic acid tert-butyl ester
|
|
C15H19NO4
|
|
|
6-Hydroxychlorzoxazone-D2,15N
|
|
|
|
3-(Hydroxymethyl)-6-methyl-1H-indole-1-carboxylic acid tert-butyl ester
|
|
C15H19NO3
|
|
16β-Hydroxyfurazabol
|
36455-74-0
|
C20H30N2O3
|
|
1-[3-(1-Hydroxy-2,2,2-trifluoroethyl)pyrrolidin-1-yl]-2,2,2-trifluoroethan-1-one
|
|
C8H9F6NO2
|
|
4-Hydroxy-2-methyl-2H-indazole
|
|
C8H8N2O
|
|
2-Hydroxy-6-(prop-1-yl)-4-(trifluoromethyl)pyridine
|
|
C9H10F3NO
|
|
4α-Hydroxystanozolol
|
100356-20-5
|
C21H32N2O2
|
|
3-(Hydroxymethyl)-7-methyl-1H-indole-1-carboxylic acid tert-butyl ester
|
|
C15H19NO3
|
|
4-Hydroxy-2-(pyridin-4-yl)-6-(trifluoromethyl)pyrimidine
|
204394-60-5
|
C10H6F3N3O
|
|
2-[Hydroxy(phenyl)phosphoryl]-1-methyl-1H-benzimidazole
|
172753-91-2
|
C14H13N2O2P
|
|
|
5-Hydroxyindole-4,6,7-D3-3-acetic-D2 Acid (5-HIAA-D5)
|
|
|
|
16β-Hydroxymestanolone
|
863760-64-9
|
C20H32O3
|
|
3-Hydroxystanozolol glucuronide (Qualitative)
|
361432-41-9
|
C27H40N2O8
|
|
|
17β-Hydroxy-17α-methyl-5α-androst-1-ene-3-one
|
|
|
|
|
α-Hydroxymidazolam-D4
|
|
|
|
1-Hydroxy-6-(methylsulphonyl)-1H-indole
|
|
C9H9NO3S
|
|
3-(4-Hydroxy-3-Methoxyphenyl)propyl tetracosanoate
|
98770-70-8
|
C34H60O4
|
|
4-hydroxythieno[3,2-c]pyridine-7-carbonitrile
|
55040-34-1
|
C8H4N2OS
|
|
2-(hydroxyMethyl)-2-p-tolylpropane-1,3-diol
|
|
C11H16O3
|
|
4-hydroxy-3,4-dihydropyrrolo[1,2-c]pyriMidin-1(2H)-one
|
223432-95-9
|
C7H8N2O2
|
|
7-hydroxy-5-oxo-4,5-dihydrothieno[3,2-b]pyridine-6-carboxylic acid
|
1936258-49-9
|
C8H5NO4S
|
|
2-Hydroxy-6-Methylbenzoyl chloride
|
1261649-90-4
|
C8H7ClO2
|
|
5-(4-Hydroxybutyn-1-yl)uridine
|
85267-67-0
|
C13H16N2O7
|